- Home
- SMTI vs EOD Comparison
SMTI vs EOD Comparison
Compare SMTI & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- EOD
- Stock Information
- Founded
- SMTI 1982
- EOD 2007
- Country
- SMTI United States
- EOD United States
- Employees
- SMTI 141
- EOD N/A
- Industry
- SMTI Medical/Dental Instruments
- EOD Investment Managers
- Sector
- SMTI Health Care
- EOD Finance
- Exchange
- SMTI Nasdaq
- EOD Nasdaq
- Market Cap
- SMTI 251.6M
- EOD 245.0M
- IPO Year
- SMTI N/A
- EOD N/A
- Fundamental
- Price
- SMTI $29.25
- EOD $5.70
- Analyst Decision
- SMTI Strong Buy
- EOD
- Analyst Count
- SMTI 2
- EOD 0
- Target Price
- SMTI $50.00
- EOD N/A
- AVG Volume (30 Days)
- SMTI 22.8K
- EOD 118.1K
- Earning Date
- SMTI 11-12-2025
- EOD 01-01-0001
- Dividend Yield
- SMTI N/A
- EOD 9.28%
- EPS Growth
- SMTI N/A
- EOD N/A
- EPS
- SMTI N/A
- EOD N/A
- Revenue
- SMTI $97,241,894.00
- EOD N/A
- Revenue This Year
- SMTI $24.49
- EOD N/A
- Revenue Next Year
- SMTI $14.43
- EOD N/A
- P/E Ratio
- SMTI N/A
- EOD N/A
- Revenue Growth
- SMTI 34.29
- EOD N/A
- 52 Week Low
- SMTI $23.53
- EOD $3.73
- 52 Week High
- SMTI $39.08
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- SMTI 44.28
- EOD 53.11
- Support Level
- SMTI $28.00
- EOD $5.60
- Resistance Level
- SMTI $30.99
- EOD $5.75
- Average True Range (ATR)
- SMTI 1.35
- EOD 0.07
- MACD
- SMTI -0.29
- EOD -0.00
- Stochastic Oscillator
- SMTI 24.86
- EOD 59.09
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.